210 related articles for article (PubMed ID: 22268453)
1. Synthesis, molecular docking, and biofilm formation inhibitory activity of 5-substituted 3,4-dihalo-5h-furan-2-one derivatives on Pseudomonas aeruginosa.
Liu GY; Guo BQ; Chen WN; Cheng C; Zhang QL; Dai MB; Sun JR; Sun PH; Chen WM
Chem Biol Drug Des; 2012 May; 79(5):628-38. PubMed ID: 22268453
[TBL] [Abstract][Full Text] [Related]
2. Furanone derivatives as quorum-sensing antagonists of Pseudomonas aeruginosa.
Kim C; Kim J; Park HY; Park HJ; Lee JH; Kim CK; Yoon J
Appl Microbiol Biotechnol; 2008 Aug; 80(1):37-47. PubMed ID: 18566810
[TBL] [Abstract][Full Text] [Related]
3. Molecular docking, and anti-biofilm activity of gold-complexed sulfonamides on Pseudomonas aeruginosa.
Mizdal CR; Stefanello ST; Nogara PA; Antunes Soares FA; de Lourenço Marques L; de Campos MMA
Microb Pathog; 2018 Dec; 125():393-400. PubMed ID: 30290269
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of 4-(alkyloxy)-6-methyl-2H-pyran-2-one derivatives as quorum sensing inhibitors.
Park S; Kim HS; Ok K; Kim Y; Park HD; Byun Y
Bioorg Med Chem Lett; 2015 Aug; 25(15):2913-7. PubMed ID: 26048802
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability-enhanced Resveramax™ modulates quorum sensing and inhibits biofilm formation in Pseudomonas aeruginosa PAO1.
Vasavi HS; Sudeep HV; Lingaraju HB; Shyam Prasad K
Microb Pathog; 2017 Mar; 104():64-71. PubMed ID: 28065820
[TBL] [Abstract][Full Text] [Related]
6. γ-Alkylidene-γ-lactones and isobutylpyrrol-2(5H)-ones analogues to rubrolides as inhibitors of biofilm formation by gram-positive and gram-negative bacteria.
Pereira UA; Barbosa LC; Maltha CR; Demuner AJ; Masood MA; Pimenta AL
Bioorg Med Chem Lett; 2014 Feb; 24(4):1052-6. PubMed ID: 24484899
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of the quorum sensing inhibitory effect of substituted triazolyldihydrofuranones.
Brackman G; Risseeuw M; Celen S; Cos P; Maes L; Nelis HJ; Van Calenbergh S; Coenye T
Bioorg Med Chem; 2012 Aug; 20(15):4737-43. PubMed ID: 22748377
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-biofilm activities of dihydro-pyrrol-2-one derivatives on Pseudomonas aeruginosa.
Ye Y; Fang F; Li Y
Bioorg Med Chem Lett; 2015 Feb; 25(3):597-601. PubMed ID: 25537269
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship of 2-hydroxy-2-aryl-2,3-dihydro-imidazo[1,2-a]pyrimidinium salts and 2N-substituted 4(5)-aryl-2-amino-1H-imidazoles as inhibitors of biofilm formation by Salmonella Typhimurium and Pseudomonas aeruginosa.
Steenackers HP; Ermolat'ev DS; Savaliya B; Weerdt AD; Coster DD; Shah A; Van der Eycken EV; De Vos DE; Vanderleyden J; De Keersmaecker SC
Bioorg Med Chem; 2011 Jun; 19(11):3462-73. PubMed ID: 21550812
[TBL] [Abstract][Full Text] [Related]
10. Structure-Activity Relationships of 6- and 8-Gingerol Analogs as Anti-Biofilm Agents.
Choi H; Ham SY; Cha E; Shin Y; Kim HS; Bang JK; Son SH; Park HD; Byun Y
J Med Chem; 2017 Dec; 60(23):9821-9837. PubMed ID: 29135250
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship of 4(5)-aryl-2-amino-1H-imidazoles, N1-substituted 2-aminoimidazoles and imidazo[1,2-a]pyrimidinium salts as inhibitors of biofilm formation by Salmonella typhimurium and Pseudomonas aeruginosa.
Steenackers HP; Ermolat'ev DS; Savaliya B; De Weerdt A; De Coster D; Shah A; Van der Eycken EV; De Vos DE; Vanderleyden J; De Keersmaecker SC
J Med Chem; 2011 Jan; 54(2):472-84. PubMed ID: 21174477
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of halogenated furanone derivatives as quorum sensing inhibitors in Pseudomonas aeruginosa.
Chang Y; Wang PC; Ma HM; Chen SY; Fu YH; Liu YY; Wang X; Yu GC; Huang T; Hibbs DE; Zhou HB; Chen WM; Lin J; Wang C; Zheng JX; Sun PH
Eur J Pharm Sci; 2019 Dec; 140():105058. PubMed ID: 31472255
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of 2-substituted 3-hydroxy-6-methyl-4H-pyran-4-one derivatives as Pseudomonas aeruginosa biofilm inhibitors.
Li YB; Liu J; Huang ZX; Yu JH; Xu XF; Sun PH; Lin J; Chen WM
Eur J Med Chem; 2018 Oct; 158():753-766. PubMed ID: 30245399
[TBL] [Abstract][Full Text] [Related]
14. Identification of LasR ligands through a virtual screening approach.
Skovstrup S; Le Quement ST; Hansen T; Jakobsen TH; Harmsen M; Tolker-Nielsen T; Nielsen TE; Givskov M; Taboureau O
ChemMedChem; 2013 Jan; 8(1):157-63. PubMed ID: 23203920
[TBL] [Abstract][Full Text] [Related]
15. Tyrosyl-tRNA synthetase inhibitors as antibacterial agents: synthesis, molecular docking and structure-activity relationship analysis of 3-aryl-4-arylaminofuran-2(5H)-ones.
Xiao ZP; Ma TW; Liao ML; Feng YT; Peng XC; Li JL; Li ZP; Wu Y; Luo Q; Deng Y; Liang X; Zhu HL
Eur J Med Chem; 2011 Oct; 46(10):4904-14. PubMed ID: 21856050
[TBL] [Abstract][Full Text] [Related]
16. [Effects of erythromycin and fosfomycin on Pseudomonas aeruginosa biofilm in vitro].
Xu Z; Liu F; Wang X
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):342-4. PubMed ID: 11802985
[TBL] [Abstract][Full Text] [Related]
17. Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control.
Bjarnsholt T; Tolker-Nielsen T; Høiby N; Givskov M
Expert Rev Mol Med; 2010 Apr; 12():e11. PubMed ID: 20370936
[TBL] [Abstract][Full Text] [Related]
18. Sub-minimum inhibitory concentrations of ceftazidime inhibit Pseudomonas aeruginosa biofilm formation.
Otani S; Hiramatsu K; Hashinaga K; Komiya K; Umeki K; Kishi K; Kadota JI
J Infect Chemother; 2018 Jun; 24(6):428-433. PubMed ID: 29449129
[TBL] [Abstract][Full Text] [Related]
19. Molecular docking and biological evaluation of novel urea-tailed mannich base against Pseudomonas aeruginosa.
Mohanvel SK; Ravichandran V; Kamalanathan C; Satish AS; Ramesh S; Lee J; Rajasekharan SK
Microb Pathog; 2019 May; 130():104-111. PubMed ID: 30849491
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antibiotic susceptibility and plasmid content, between biofilm producing and non-producing clinical isolates of Pseudomonas aeruginosa.
Delissalde F; Amábile-Cuevas CF
Int J Antimicrob Agents; 2004 Oct; 24(4):405-8. PubMed ID: 15380270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
